IL151683A0 - Composition for use in treatment of ocular hypertension and glaucoma - Google Patents

Composition for use in treatment of ocular hypertension and glaucoma

Info

Publication number
IL151683A0
IL151683A0 IL15168301A IL15168301A IL151683A0 IL 151683 A0 IL151683 A0 IL 151683A0 IL 15168301 A IL15168301 A IL 15168301A IL 15168301 A IL15168301 A IL 15168301A IL 151683 A0 IL151683 A0 IL 151683A0
Authority
IL
Israel
Prior art keywords
glaucoma
treatment
composition
ocular hypertension
ocular
Prior art date
Application number
IL15168301A
Other languages
English (en)
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/730,830 external-priority patent/US20010034355A1/en
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of IL151683A0 publication Critical patent/IL151683A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15168301A 2000-03-16 2001-03-15 Composition for use in treatment of ocular hypertension and glaucoma IL151683A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52757300A 2000-03-16 2000-03-16
US09/730,830 US20010034355A1 (en) 2000-03-16 2000-12-07 Treatment of ocular hypertension
PCT/JP2001/002035 WO2001068072A2 (en) 2000-03-16 2001-03-15 Composition for use in treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
IL151683A0 true IL151683A0 (en) 2003-04-10

Family

ID=27062443

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15168301A IL151683A0 (en) 2000-03-16 2001-03-15 Composition for use in treatment of ocular hypertension and glaucoma

Country Status (18)

Country Link
US (1) US20010056104A1 (xx)
EP (1) EP1272194A2 (xx)
JP (1) JP2003526660A (xx)
KR (1) KR20080012407A (xx)
CN (1) CN100506232C (xx)
AR (1) AR029818A1 (xx)
AU (2) AU2001241143B2 (xx)
BR (1) BR0109192A (xx)
CA (1) CA2402597C (xx)
CZ (1) CZ20023092A3 (xx)
HU (1) HUP0300391A3 (xx)
IL (1) IL151683A0 (xx)
MX (1) MXPA02008967A (xx)
NO (1) NO20024381L (xx)
NZ (1) NZ521325A (xx)
RU (1) RU2002127733A (xx)
TW (1) TWI286932B (xx)
WO (1) WO2001068072A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL124620A0 (en) † 1995-12-18 1998-12-06 Myriad Genetics Inc Chromosome 13-linked breast cancer susceptibility gene
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
EP1411950A2 (en) * 2001-07-31 2004-04-28 Sucampo AG Treatment of ocular hypertension and glaucoma
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0569046B1 (en) * 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
WO1999032441A1 (en) * 1997-12-22 1999-07-01 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
DK1069913T3 (da) * 1998-04-07 2003-11-17 Alcon Mfg Ltd Gelatinering af ophthalmiske sammensætninger indeholdende xanthangummi

Also Published As

Publication number Publication date
WO2001068072A3 (en) 2002-06-06
CN1429112A (zh) 2003-07-09
TWI286932B (en) 2007-09-21
AU2001241143B2 (en) 2005-08-25
HUP0300391A2 (hu) 2003-06-28
US20010056104A1 (en) 2001-12-27
CA2402597C (en) 2011-04-26
BR0109192A (pt) 2003-05-27
NO20024381L (no) 2002-11-15
AU4114301A (en) 2001-09-24
CN100506232C (zh) 2009-07-01
HUP0300391A3 (en) 2008-05-28
CA2402597A1 (en) 2001-09-20
JP2003526660A (ja) 2003-09-09
NO20024381D0 (no) 2002-09-13
AR029818A1 (es) 2003-07-16
CZ20023092A3 (cs) 2003-05-14
MXPA02008967A (es) 2003-02-12
RU2002127733A (ru) 2004-03-27
WO2001068072A2 (en) 2001-09-20
KR20080012407A (ko) 2008-02-11
EP1272194A2 (en) 2003-01-08
NZ521325A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
AU6118001A (en) Combination therapeutic compositions and methods of use
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
EP1210063A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING THE ABSORPTION OF HYDROPHILIC THERAPEUTIC ACTIVE SUBSTANCES
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
HK1049115A1 (zh) 治療過敏性失調的成分和方法
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
AU2002240463A1 (en) Use of endostatin in the treatment of ocular neovascularization
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
IL151683A0 (en) Composition for use in treatment of ocular hypertension and glaucoma
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
ZA200400210B (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
AU2002337983A1 (en) Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis
IL152782A0 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.
AU2002350828A1 (en) Use of dendrimers in an ophthalmic composition
AU2001216038A1 (en) Treatment of glaucoma and ocular hypertension
AU2003216547A8 (en) Compositions and methods for treating glaucoma and ocular hypertension

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees